A Multicenter, Randomized, Double-Blind Study of the Safety and Efficacy of Calcipotriene Foam, 0.005%, Versus Vehicle Foam In The Treatment Of Moderate Plaque-Type Scalp And Body Psoriasis.
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 11 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2010 Planned End Date changed from 1 Mar 2011 to 1 Jan 2011.
- 04 Nov 2010 Status changed from recruiting to active, no longer recruiting.